Journal of Hematology & Oncology

official impact factor 2.93

This article is part of the supplement: Current trends in leukemia, lymphoma, myeloma and ITP: updates and highlights from ASH 2008

Open Access Meeting abstract

Update on chronic immune thrombocytopenic purpura (ITP)

Robert McMillan

Journal of Hematology & Oncology 2009, 2(Suppl 1):A5 doi:10.1186/1756-8722-2-S1-A5

No comments have yet been made on this article.

Post a comment